GLP-1
Showing 1 - 25 of >10,000
GLP-1, Gut Microbiota Trial in Mexico City (sucralose, )
Recruiting
- GLP-1
- Gut Microbiota
- sucralose
- placebo
-
Mexico City, MexicoInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubi
Oct 17, 2023
Gastric Ultrasound Assessment for Patients Taking GLP1 Agonists
Not yet recruiting
- Gastric Ultrasound
- +2 more
- Gastric Ultrasound Exam
- (no location specified)
Aug 15, 2023
Morbid Obesity, Metabolic Syndrome, Diabetes Trial in Columbia (GLP-1 receptor agonist)
Not yet recruiting
- Morbid Obesity
- +4 more
- GLP-1 receptor agonist
-
Columbia, MissouriUniversity of Missouri Hospital
Nov 20, 2023
Gastric Volume in Patients on GLP-1 Medications
Recruiting
- Diabetes
- None - observational
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Jun 6, 2023
Effects of GLP-1 Agonists on Gastric Volume
Not yet recruiting
- Diabetes
- +3 more
- Gastric Ultrasound
-
Charleston, South CarolinaMedical University of South Carolina
May 10, 2023
Incidence of Retained Gastric Food on Endoscopy
Not yet recruiting
- Gastric Content Aspiration
- Esophagogastroduodenoscopy
- (no location specified)
May 16, 2023
Obesity, Liver Diseases, Liver Fibrosis Trial in Boston (ESG, GLP1-RA)
Not yet recruiting
- Obesity
- +16 more
- ESG
- GLP1-RA
-
Boston, MassachusettsBrigham and Women's Hospital
Nov 14, 2023
Type II Diabetes Trial in Dijon (drug, procedure, other)
Recruiting
- Type II Diabetes
- GLP-1 agonists
- +2 more
-
Dijon, FranceChu Dijon Bourgogne
Jan 2, 2023
Diabetes Trial in Nanjing (Duragtide, Semaglutide, losenatide, tirzepatide, ebenatide, etc)
Recruiting
- Diabetes
- Duragtide, Semaglutide, losenatide, tirzepatide, ebenatide, etc
-
Nanjing, ChinaNanjing First Hospital, Nanjing Medical Univesity
Aug 6, 2023
Delayed Gastric Emptying, Gastroparesis Trial in Chapel Hill (gastric ultrasound)
Not yet recruiting
- Delayed Gastric Emptying
- Gastroparesis
- gastric ultrasound
-
Chapel Hill, North CarolinaUniversity of North Carolina Medical Center
Sep 8, 2023
Caveolin 1 Deficiency in Response to Glucagon-like Peptide 1
Not yet recruiting
- Overweight and Obesity
- 24-hour ambulatory blood pressure
- Liberal salt diet
- (no location specified)
Oct 4, 2023
Type 1 Diabetes Trial (Semaglutide weekly injection)
Not yet recruiting
- Type 1 Diabetes
- Semaglutide weekly injection
- (no location specified)
Sep 21, 2023
GLP-1RAs) and SGLT2is Combination Therapy and MACEs in Type 2
Recruiting
- Diabetes Mellitus, Type 2
- Myocardial Infarction
- PCI
-
Naples, ItalyCelestino Sardu
Aug 31, 2023
Cystic Fibrosis, Cystic Fibrosis-related Diabetes Trial in Minneapolis (Semaglutide)
Not yet recruiting
- Cystic Fibrosis
- Cystic Fibrosis-related Diabetes
-
Minneapolis, MinnesotaUniversity of Minnesota
Mar 15, 2023
Obesity Trial in Hamburg (GLP-1 (Liraglutide), Placebo)
Terminated
- Obesity
- GLP-1 (Liraglutide)
- Placebo
-
Hamburg, GermanyUniversity Medical Center Hamburg
Jun 29, 2022
Type 2 Diabetes, Diabetes, Type 2 Trial (Tirzepatide)
Not yet recruiting
- Type 2 Diabetes
- Diabetes Mellitus, Type 2
- (no location specified)
Feb 6, 2023
Obesity Trial in Singapore (Endoscopic sleeve gastroplasty)
Not yet recruiting
- Obesity
- Endoscopic sleeve gastroplasty
-
Singapore, SingaporeSengkang General Hospital
Oct 4, 2022
Testing the Effectiveness of WW + Sequence GLP1 (WW+Sequence)
Enrolling by invitation
- Weight Loss
- Obesity
-
Cleveland, OhioCleveland Clinic
Sep 5, 2023
Type 2 Diabetes Trial in Lancaster (Exenatide Injection, Saline injection)
Terminated
- Type 2 Diabetes
- Exenatide Injection
- Saline injection
-
Lancaster, PennsylvaniaAmish Research Clinic
Mar 6, 2023
Type 1 Diabetes Trial in Kuwait City (drug, other, procedure)
Not yet recruiting
- Type 1 Diabetes
- Liraglutide / Semaglutide
- +4 more
-
Kuwait City, Al Asimah, KuwaitDasman Diabetes Institute
Jan 8, 2023
Osteoporosis, Postmenopausal, Diabetes, Type 2 Trial in Jackson (GLP-1 receptor agonist)
Recruiting
- Osteoporosis, Postmenopausal
- Diabetes Mellitus, Type 2
- GLP-1 receptor agonist
-
Jackson, MississippiUniversity of Mississippi Medical Center
Aug 5, 2022
Obesity Trial in Ras al-Khaimah (POSE2.0 Endoscopic Gastric Remodeling, Liraglutide injection)
Recruiting
- Obesity
- POSE2.0 Endoscopic Gastric Remodeling
- Liraglutide injection
-
Ras al-Khaimah, United Arab EmiratesIbrahim Bin Hamad Obaidullah Hospital
Jan 27, 2023
Comparison of Type 2 Diabetes Pharmacotherapy Regimens
Recruiting
- Type 2 Diabetes Mellitus
- Cardiovascular Diseases
- SU
- +13 more
-
Oakland, California
- +5 more
Oct 18, 2022
Glucagon-like Peptide 1 Receptor Agonists and Mental Health
Not yet recruiting
- Diabetes Mellitus
- +2 more
- GLP-1 receptor agonist
- (no location specified)
Aug 4, 2022